Pro
Rheumatology reported in a Jan. 2006 article titled "Preliminary Assessment of The Efficacy, Tolerability and Safety of A Cannabis-based Medicine (Sativex) in The Treatment of Pain Caused By Rheumatoid Arthritis," by D.R. Blake et al.:
“In comparison with placebo, the CBM [cannabis-based medicine] produced statistically significant improvements in pain on movement, pain at rest, quality of sleep….
In the first ever controlled trial of a CBM in RA [rheumatoid arthritis], a significant analgesic effect was observed and disease activity was significantly suppressed following Sativex treatment.”
Jan. 2006